Between January and April 2018, Russia imported 30.9 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 31% higher than that of the same period of 2017. In physical terms, Russia imported 3,440 tons of APIs, which is 3.6% higher than that of the same period of 2017.

The April performance contributed to the current dynamics. In April 2018, Russia imported 8.85 bln RUB worth of API (free circulation prices), VAT included), which is in monetary terms 38% higher than that of April 2017. The dynamics of the import of technical and pharmacopoeial APIs in monetary terms were 380% and 34%, respectively. In physical terms, the dynamics were -23% and -16%.

The import line and prices have also changed over the period. The number of imported pharmacopoeial APIs has risen by 9, to 411, while the number of imported technical APIs has fallen by 7, to 65.

The average cost of the comparable pharmacopoeial API names (which are supplied both in the reporting and comparison periods) has risen by 12%, while the average cost of technical APIs has risen by 2.7 times.

The leaders in the dynamics of the import of pharmacopoeial APIs in monetary terms are Mebeverinum (28 times increase) and Valsartanum (8.5 times increase). The main importers of Mebeverinum are Veropharm and Canonpharma Productions, while the biggest imported of Valsartanum is KRKA.

As for technical APIs, Linezolidum is the most imported one among the 8 APIs that were last imported in 2010, with 65 kg. It was imported by Rozleks Farm (Tver Oblast) for the production of Roulin-Rowtech.

Dynamics of import of pharmacopoeial and technical APIs to Russia (2015 – 2017, January – April 2018), bln RUB